Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Mo Qatanani | CHIEF SCIENTIFIC OFFICER | 2025-01-16 | 7,347 | $44.20 | $324.72kSell |
Jay T. Backstrom | CHIEF EXECUTIVE OFFICER | 2025-01-16 | 22,308 | $44.20 | $985.95kSell |
Edward H. Myles | COO CFO | 2025-01-16 | 12,539 | $44.20 | $554.19kSell |
Caryn Parlavecchio | CHRO | 2025-01-16 | 6,434 | $44.20 | $284.36kSell |
Jing L. Marantz | CHIEF MEDICAL OFFICER | 2025-01-16 | 5,655 | $44.20 | $249.93kSell |
Junlin Ho | GENERAL COUNSEL | 2025-01-16 | 9,039 | $44.20 | $399.50kSell |
Tracey Sacco | Chief Commercial Officer | 2025-01-16 | 3,890 | $44.20 | $171.93kSell |
Invus Public Equities LP | 10% Owner | 2024-12-10 | 1,600,000 | $41.65 | $66.64MSell |
Jing L. Marantz | CHIEF MEDICAL OFFICER | 2024-11-25 | 2,100 | $39.25 | $82.43kSell |
Jing L. Marantz | CHIEF MEDICAL OFFICER | 2024-11-25 | 3,075 | $39.93 | $122.78kSell |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Srinivas Akkaraju | 17.63% | 16,503,833 | $629.46M | Insider |
Siren LLC | 12.03% | 11,259,438 | $429.43M | Insider |
Siren LLC | 12.03% | 11,259,438 | $429.43M | Institution |
Fmr LLC | 10.89% | 10,196,046 | $388.88M | Institution |
Invus Public Equities LP | 9.88% | 9,250,005 | $352.80M | Insider |
Price T Rowe Associates Inc | 9.24% | 8,654,106 | $330.07M | Institution |
Samsara Biocapital LLC | 7.25% | 6,788,609 | $258.92M | Institution |
Samsara Biocapital GP LLC | 7.25% | 6,788,609 | $258.92M | Insider |
Blackrock Inc 1 | 6.58% | 6,155,464 | $234.77M | Institution |
Blackrock Inc | 6.58% | 6,155,464 | $234.77M | Institution |